Potential utility of <i>FGFR2</i> mutation status as an adverse prognostic factor to affect clinical decision-making.

<p>The decision tree is adapted from 2011 National Comprehensive Cancer Network guidelines using FIGO 2009 staging. BT = brachytherapy; RT = radiation therapy.</p>